Displaying items by tag: department of neurology

A new screening tool developed at UAB has been shown to be an effective aid in determining the severity of cognitive issues.
The FDA's approval of Epiliodex could open the door for increased research of cannabis-based therapies, says UAB researcher.
More than a third of people have the biology of Alzheimer’s disease but not the symptoms. Understanding why could lead to new therapies.
The Blazer Bolt for Brain Cancer boasts record attendance as it raises money for brain tumor research
UAB investigators are looking at the intriguing possibility of a connection between the gut microbiome and Parkinson’s disease.
Researchers will delve into the role of inflammation and the immune system in the worsening of Parkinson’s disease as UAB is named a Udall Center of Excellence.
UAB was part of a national, multisite study that showed a drug for multiple sclerosis was effective in slowing down brain atrophy, or shrinkage.
The goal is an early warning system to block incipient seizures for patients where medications have failed.
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
UAB's study of CBD oil for intractable epilepsy, funded by the State of Alabama under Carly's Law, shows that CBD oil reduces seizure frequency and severity in patients with treatment-resistant epilepsy.
UAB is renewed for another five years in NeuroNEXT, a national clinical research program in brain disorders.
The body’s autonomic nervous system affects involuntary actions, such as heart beat and breathing, and UAB opens a new tool to help diagnose autonomic-related conditions.
A neuron model of Parkinson’s disease and Lewy body dementias shows defects that could suggest treatments to halt or reverse cognitive impairments before the neurons die.
UAB investigators look at a gene therapy technique that helps cells take out the trash.
Page 4 of 11